May 20 |
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
|
May 20 |
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform
|
May 20 |
Weight loss: Hims & Hers introduce access to GLP-1 injections
|
May 20 |
Hims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutide
|
May 20 |
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
|
May 16 |
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
|
May 15 |
High Insider Ownership Growth Stocks On US Exchange For May 2024
|
May 9 |
10 Solid Reasons To Buy Hims & Hers Stock
|
May 9 |
Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
|
May 8 |
Hims & Hers: Strong Operating Leverage And Profitability Inflection
|